• “Doing a great job - payments have always been on time, and correct. We're happy.” – SCLRC Member Site
 
OUR SERVICES
Advisory Boards
Central Budgets
Clinical Trial Design
CME Training
Consortium-wide Research Guidelines CRO Collaboration
Design/Review Protocol  
Hold INDs
Investigator Meetings
Investigator Recruitment
Master Contracts
Patient Recruitment Options
PK Facilities
Project Management
Site Selection
80+ sites ready to do Phase I-IV trials
  The SC Liver Research Consortium (SCLRC) is an organization of physicians specializing in hepatology and gastroenterology clinical research. SCLRC's mission is to team research sponsors and SCLRC's over 80 research sites together to provide faster, higher-quality research results compared to the current "conventional" sponsor-site arrangement. This is accomplished by providing streamlined contract and budget negotiations, access to our scientific expertise in study design, efficient site selection, and ongoing site evaluation.

Dr. Paul Pockros is President of SCLRC and practices out of Scripps Clinic in La Jolla, California. In addition to being one of the lead clinical researchers and a key opinion leader in liver disease, he treats hepatology and gastroenterology patients daily at Scripps Clinic as Head of the Hepatology/ Gastroenterology Department. He is also Clinical Director of the Scripps Translational Science Institute. He has over 27 years of clinical research experience.

Let us tighten your protocol, connect you with the best research centers for enrollment of your protocol, and help you meet your study timelines for a successful clinical trial. To get started, call us at 1-858-692-9887 or fax us your non-disclosure agreement 1-858-373-2171. Find answers to frequently asked questions on our SERVICES page. We are your link to a successful clinical research trial.

 
NEWS BRIEFS

SC Liver Research Consortium signs agreement with Cepheid to help manage a clinical evaluation of the Xpert® HVC VL Assay for the management of HCV patients.
Posted 10 Dec, 2014

SC Liver Research Consortium signs contract with Conatus Pharmaceuticals Inc. to manage their Phase 2 study to evaluate Conatus’ compound IDN-6556 in Subjects Cirrhotic Subjects with Portal Hypertension
Posted 1 Jul, 2014

SC Liver Research Consortium signs contract with Conatus Pharmaceuticals Inc. to manage their Phase 2 study to evaluate Conatus’ compound IDN-6556 in Subjects with Liver Cirrhosis
Posted 16 Jun, 2014

SC Liver Research Consortium signs contract with Roche Molecular Systems to manage their protocol to evaluate their assays and instrumentation for the management of HCV patients
Posted 17 Apr, 2014

SC Liver Research Consortium signs contract with Conatus Pharmaceuticals Inc. to manage their Phase 2 study to evaluate Conatus’ compound IDN-6556 in subjects who had HCV reinfection and liver fibrosis or cirrhosis following orthotopic liver transplantation for chronic HCV Infection and who subsequently achieved a sustained virologic response following anti-HCV therapy
Posted 17 Mar, 2014

SC Liver Research Consortium signs contract with Janssen Services, LLC to fund an Investigator Initiated study of Simeprevir + Sofosbuvir with or without Ribavirin for Interferon-intolerant or ineligible patients with CHC
Posted 12 Feb, 2014

SC Liver Research Consortium signs contract with Beckman Coulter, Inc. to manage their upcoming protocol to evaluate their DxN HBV Viral Load Assay
Posted 8 Feb, 2014

     
 

Copyright ©   SCLRC - SC Liver Research Consortium LLC  All rights reserved
2683 Villa de la Valle, Suite G, CA 92014 and 2638 Hooch Court, Duluth, GA 30097

858-692-9887


site created by THE CODE CREW